CELC vs CYTK Stock Comparison
CELC currently leads CYTK in this stock comparison, with AIQ scores of 41 vs 40. The clearest difference is quality, while CYTK has the stronger risk resilience profile.
What is the main difference between CELC and CYTK?
CELC leads the current stock comparison as Celcuity Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Celcuity Inc. vs Cytokinetics, Incorporated
CELC leads
CELC leads by 1 AIQ points, primarily on Quality, having only recently taken the lead back from CYTK.
Fragile: 1 of 5 evidence groups support CELC, and the lead recently changed hands.
Celcuity Inc.
Cytokinetics, Incorporated
The Algovestiq AIQ Score currently favors CELC over CYTK, 41 versus 40 as of Nov 15, 2026. CELC's advantage is driven primarily by stronger quality, while CYTK holds the stronger risk resilience profile. CELC also shows the stronger technical structure relative to its 50-day moving average. 1 of 5 covered evidence groups favor CELC today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. CELC lead: Reversed — CYTK led by 5 AIQ points 30 sessions ago; CELC now leads by 1.
Compare Celcuity Inc. and Cytokinetics, Incorporated across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare CELC and CYTK against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience34 vs 56CYTK +22
- Quality63 vs 46CELC +17
- Momentum24 vs 28CYTK +4
1 of 5 evidence groups favor CELC. CELC’s edge is concentrated in quality; CYTK keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
No factor moved materially.
No signal started or stopped since the prior session; its 5 active signals are unchanged.
Largest factor move: Momentum -3
New signals
- 52-Week Low Proximity — bearish, risk_regime, long horizon (3.0%)
CELC's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — CELC and CYTK both carry a full feed there.
The central trade-off
CELC (Celcuity Inc.): the stronger current systematic profile, led by quality.
CYTK (Cytokinetics, Incorporated): the counter-case, on risk resilience, momentum, technicals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
CELCCELC on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
CYTKCYTK on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
CYTKCYTK on the Momentum factor, by 4 points.
Lower downside
CYTKCYTK on Risk Resilience, by 22 points.
Analyst upside
CELCCELC on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | CELC | CYTK | Note |
|---|---|---|---|
| Implied upside to target | +146.2% | +77% | CELC has more room |
| Target dispersion | +23.3% | +32.2% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 13 | 22 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
1 of 5 covered evidence groups favor CELC. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 41 vs 40 |
| Fundamentals | Even | EPS growth 7.6% vs 8.7%; TTM ROE 99.1% vs 59.2% |
| Valuation | Not covered | Not covered |
| Technicals | CYTK | Price vs 50-day -11.2% vs -12.5%; vs 200-day -34.6% vs -19.6% |
| Risk Resilience | CYTK | Risk Resilience 34 vs 56 |
| Analyst expectations | CELC | Target upside 146.2% vs 77% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CELC and CYTK and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
- Only 1 of 5 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CELC.
How the comparison changed
120 daily snapshots · May 27 – Nov 13CELC lead: Reversed — CYTK led by 5 AIQ points 30 sessions ago; CELC now leads by 1.
- Today
- CELC +1
- 41 vs 40
- 7 sessions ago
- CELC +1
- 42 vs 41
- 30 sessions ago
- CYTK +5
- 40 vs 45
- 90 sessions ago
- CYTK +5
- 47 vs 52
The lead changed hands 2 times in this window, most recently on Nov 3 when CELC moved ahead of CYTK.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
0 bullish / 3 bearish / 2 neutral
Only CELC
- ADX Trend Weakening — neutral, trend, medium horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.52x)
0 bullish / 3 bearish / 1 neutral
Only CYTK
- 52-Week Low Proximity — bearish, risk_regime, long horizon (3.0%)
Both carry 3 more signals that do not separate them: Death Cross Active, ATR Expansion - Breakout Mode, Downtrend Structure Active.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.31%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.05%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1CYTK closes the Quality gap — currently 17 points behind, the largest single contributor to CELC's edge.
- 2CYTK's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3CELC starts generating bearish momentum or trend signals.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | CELC | CYTK |
|---|---|---|
| Revenue growth (YoY) | 0% | 66.1% |
| EPS growth (YoY) | 7.6% | 8.7% |
| Gross margin | 0% | 91% |
| Operating margin | 0% | -6.3% |
| Return on equity (TTM) | 99.1% | 59.2% |
| Debt to equity | -10.2 | -3.96 |
Performance
CYTK leads 5 of 6 windows| Metric | CELC | CYTK |
|---|---|---|
| 1 week (5 sessions) | -3.6% | 4.5% |
| 1 month (20 sessions) | 13.8% | -9.4% |
| 3 months (63 sessions) | -30.4% | -26% |
| 6 months (126 sessions) | -53.2% | -26% |
| Year to date | -35.5% | -11.7% |
| 1 year (252 sessions) | -24.4% | -14.9% |
Technicals
CYTK has the stronger structure| Metric | CELC | CYTK |
|---|---|---|
| RSI (14) | 43.2 | 38.2 |
| ADX (14) | 17 | 25.7 |
| Price vs 50-day | -11.2% | -12.5% |
| Price vs 200-day | -34.6% | -19.6% |
| Volatility (1M, annualized) | 57.6% | 57% |
Risk
CYTK is the more resilient| Metric | CELC | CYTK |
|---|---|---|
| Beta | 1.12 | 1.01 |
| Sharpe ratio | -0.19 | -0.23 |
| Sortino ratio | -0.25 | -0.32 |
| Max drawdown | -61% | -38.5% |
| Current drawdown | -55.6% | -35.7% |
| Annualized volatility | 63.6% | 43.7% |
| Value at risk (95%) | -6% | -4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, CELC or CYTK?
On the Algovestiq AIQ Score, CELC is the stronger of the two as of Nov 15, 2026, scoring 41 against CYTK's 40. The edge comes from quality. CYTK is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is CELC or CYTK the better buy right now?
CELC carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 1 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.
Why does the AIQ Score favor CELC over CYTK?
The composite weights Quality, Value, Momentum and Risk Resilience. CYTK leads Risk Resilience by 22 points; CELC leads Quality by 17 points; CYTK leads Momentum by 4 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, CELC or CYTK?
Analyst price targets imply +146.2% upside for CELC and +77% for CYTK, so the Street currently favors CELC. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, CELC or CYTK?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, CELC or CYTK?
CYTK on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, CELC or CYTK?
CYTK on the Momentum factor, by 4 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, CELC or CYTK?
CYTK is the more resilient of the two, so the other name carries the higher downside risk. CYTK on Risk Resilience, by 22 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is CELC more profitable than CYTK?
CELC leads on the comparable margin measures — gross margin 0% vs 91%; operating margin 0% vs -6.3%; ttm roe 99.1% vs 59.2%.
Is CELC's lead over CYTK getting stronger or weaker?
CELC lead: Reversed — CYTK led by 5 AIQ points 30 sessions ago; CELC now leads by 1. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-11-03, when CELC moved ahead of CYTK.
What would change the CELC vs CYTK verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CYTK closes the Quality gap — currently 17 points behind, the largest single contributor to CELC's edge; CYTK's Death Cross Active resolves — a bearish trend rule currently active against it; CELC starts generating bearish momentum or trend signals; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about CELC and CYTK?
CELC: 0 bullish / 3 bearish / 2 neutral. CYTK: 0 bullish / 3 bearish / 1 neutral. The most decision-relevant rule on CELC is Death Cross Active (bearish, long horizon). On CYTK it is Death Cross Active (bearish, long horizon).
Compare CELC and CYTK with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.